Reuters - Drugs used to treat malaria
appear to reduce the risk of malignancy in patients with
systemic lupus erythematosus, Spanish researchers report in the
Annals of the Rheumatic Diseases.
Source: http://rss.news.yahoo.com
Thursday, July 19, 2007
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment